Intellia therapeutics revenue
Nettet10. aug. 2024 · Following the upgrade, the most recent consensus for Intellia Therapeutics from its 22 analysts is for revenues of US$50m in 2024 which, if met, would be a solid 9.7% increase on its sales over ... Nettet6. aug. 2024 · Intellia Therapeutics, Inc.Which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $16.26 million for the quarter ended June …
Intellia therapeutics revenue
Did you know?
Nettet21. mar. 2024 · Intellia Therapeutics has 4 employees at their 1 location and $52.12 m in annual revenue in FY 2024. See insights on Intellia Therapeutics including office … Nettet13. mar. 2024 · Intellia Therapeutics's revenue was up 5.4% on a year-over-year basis. On average, equities research analysts expect that Intellia Therapeutics, Inc. will post -5.79 earnings per share for the current fiscal year. Insiders Place Their Bets. 3 Genomics Stocks to Buy Now; In other Intellia Therapeutics news, CFO Glenn Goddard the SEC …
Nettet21. mar. 2024 · Intellia Therapeutics Financials Summary financials Revenue ( FY, 2024) $52.1M Net income ( FY, 2024) ($474.2M) Cash ( FY, 2024) $523.5M EBIT ( FY, 2024) ($458.2M) Enterprise value $3.0B Competitors and similar companies Ionis Pharmaceuticals Healthcare - Public 4D Molecular Therapeutics Healthcare - Public … Nettet22. feb. 2024 · Through the first nine months of 2024, Intellia reported collaboration revenue of $38.5 million, up 91% year over year. It also reported an EPS loss of $4.78 in the period, compared to an EPS loss ...
Nettet23. feb. 2024 · Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of 0% and 11.06%, respectively, for the quarter ended December 2024. Nettet4. aug. 2024 · The Investor Relations website contains information about Intellia Therapeutics's business for stockholders, potential investors, ... Collaboration Revenue: Collaboration revenue increased by approximately $7.5 million to $14.0 million during the second quarter of 2024, ...
NettetIntellia Therapeutic’s stock (NASDAQ: NTLA), a biotechnology company developing treatments using the CRISPR gene-editing system, has seen a fall of 31% in a month, …
Nettet10. apr. 2024 · Intellia Therapeutics GAAP EPS of -$1.40 misses by $0.04, revenue of $13.6M beats by $2.89M SA News Thu, Feb. 23 7 Comments Intellia Therapeutics Q4 2024 Earnings Preview how to join a bankNettet28. jul. 2024 · As of Q121, Intellia reported a cash position of $995m, down from $1.1bn in Q121. The company earned $11.3m of collaboration revenues in Q121, and made a net loss of $147m. Net loss in FY21 was... jorja smith - addictedNettetIntellia Therapeutics, Inc. Healthcare Biotechnology USA statements Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. how to join a biker gangNettet28. jul. 2024 · Intellia in vivo pipeline. (Corporate Presentation) As of Q121, Intellia reported a cash position of $995m, down from $1.1bn in Q121. The company earned … how to join a beamng drive serverNettet3. jan. 2024 · Intellia reported positive phase 1 data this year. That's so early it's not even funny. Sooner or later there will be bad news, and you'll get a cheaper price. CRISPR has the illusion of being a... how to join abbyson sectional sofaNettetTotal Enterprise Value to Total Revenue (ttm) 39.02. ... John Leonard built Intellia Therapeutics with Jennifer Doudna, the Nobel Prize-winning scientist who pioneered gene editing technology. how to join a bike chainNettetIntellia is a pioneer in the development of CRISPR/Cas9 genome editing and is rapidly moving experimental therapies towards the clinic. Our company’s unique strengths … how to join a battleground wow